| scholarly article | Q13442814 |
| P2093 | author name string | H Peng | |
| Z Liu | |||
| L Ouyang | |||
| W-Z Zhang | |||
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor | Q22009126 | ||
| Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery | Q27860586 | ||
| NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling | Q28144330 | ||
| Proliferation, cell cycle and apoptosis in cancer | Q28189476 | ||
| Regulation of cell death protease caspase-9 by phosphorylation | Q28288607 | ||
| Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation | Q29614227 | ||
| ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions | Q29615216 | ||
| Targeting PI3K signalling in cancer: opportunities, challenges and limitations | Q29617685 | ||
| The Ste20 group kinases as regulators of MAP kinase cascades | Q29619312 | ||
| Oridonin induced A375-S2 cell apoptosis via bax-regulated caspase pathway activation, dependent on the cytochrome c/caspase-9 apoptosome | Q33199100 | ||
| Antiproliferation effects of ponicidin on human myeloid leukemia cells in vitro. | Q33212682 | ||
| Oridonin inhibits cell growth by induction of apoptosis on human hepatocelluar carcinoma BEL-7402 cells | Q33241115 | ||
| Effects of oridonin on proliferation of HT29 human colon carcinoma cell lines both in vitro and in vivo in mice. | Q33292385 | ||
| Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways | Q40435902 | ||
| Cytochrome c release from oridonin-treated apoptotic A375-S2 cells is dependent on p53 and extracellular signal-regulated kinase activation | Q40502547 | ||
| Oridonin induces a caspase-independent but mitochondria- and MAPK-dependent cell death in the murine fibrosarcoma cell line L929. | Q40507634 | ||
| Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells. | Q40636149 | ||
| Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. | Q41205566 | ||
| Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis. | Q43508536 | ||
| Oridonin enhances phagocytosis of UV-irradiated apoptotic U937 cells | Q45296035 | ||
| Molecular mechanisms of oridonin-induced apoptosis and autophagy in murine fibrosarcoma L929 cells | Q46128790 | ||
| Multiple-modulation effects of Oridonin on the production of proinflammatory cytokines and neurotrophic factors in LPS-activated microglia | Q46137751 | ||
| Involvement of PKC signal pathways in oridonin-induced autophagy in HeLa cells: a protective mechanism against apoptosis | Q46232893 | ||
| Oridonin-induced apoptosis in leukemia K562 cells and its mechanism | Q46473086 | ||
| Activation of phosphoinositide 3-kinase, protein kinase C, and extracellular signal-regulated kinase is required for oridonin-enhanced phagocytosis of apoptotic bodies in human macrophage-like U937 cells | Q46633854 | ||
| Oridonin induced autophagy in human cervical carcinoma HeLa cells through Ras, JNK, and P38 regulation | Q46840428 | ||
| Roles of Ras and extracellular signal-regulated kinase-dependent IkappaBalpha degradation in oridonin-enhanced phagocytosis of apoptotic cells by human macrophage-like U937 cells | Q46884524 | ||
| Phagocytosis of Escherichia coli by insect hemocytes requires both activation of the Ras/mitogen-activated protein kinase signal transduction pathway for attachment and beta3 integrin for internalization | Q48010805 | ||
| Targeting of AML1-ETO in t(8;21) leukemia by oridonin generates a tumor suppressor-like protein. | Q53176666 | ||
| Antitumor activity of diterpenoids, trichorabdals A, B, and C, and the related compounds: synergism of two active sites | Q71063932 | ||
| BCL-2 gene family and the regulation of programmed cell death | Q77303933 | ||
| Oridonin-induced A431 cell apoptosis partially through blockage of the Ras/Raf/ERK signal pathway | Q79656081 | ||
| Fas/FasL signaling allows extracelluar-signal regulated kinase to regulate cytochrome c release in oridonin-induced apoptotic U937 cells | Q80199791 | ||
| Autophagy enhanced phagocytosis of apoptotic cells by oridonin-treated human histocytic lymphoma U937 cells | Q82878219 | ||
| Oridonin induces apoptosis via PI3K/Akt pathway in cervical carcinoma HeLa cell line | Q33303792 | ||
| Reactive oxygen species contribute to oridonin-induced apoptosis and autophagy in human cervical carcinoma HeLa cells | Q33566142 | ||
| Autophagy counteracts apoptosis in human multiple myeloma cells exposed to oridonin in vitro via regulating intracellular ROS and SIRT1 | Q33566976 | ||
| Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc | Q33740026 | ||
| Bcl-2 family: life-or-death switch | Q33825160 | ||
| Augmentation of oridonin-induced apoptosis observed with reduced autophagy | Q33997847 | ||
| And all of a sudden it's over: mitochondrial outer-membrane permeabilization in apoptosis | Q34648801 | ||
| Initiator caspases in apoptosis signaling pathways | Q34724282 | ||
| The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. | Q34859478 | ||
| Mitochondria: releasing power for life and unleashing the machineries of death | Q35071387 | ||
| Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo | Q35751083 | ||
| Functions of the MAPK family in vertebrate-development | Q36584183 | ||
| Autophagic pathways as new targets for cancer drug development | Q36654185 | ||
| An introduction to death receptors in apoptosis | Q36802828 | ||
| Autophagy and human disease | Q36900047 | ||
| Living with death: the evolution of the mitochondrial pathway of apoptosis in animals. | Q37152726 | ||
| Autophagy and cancer: dynamism of the metabolism of tumor cells and tissues | Q37323895 | ||
| Electron microscopy morphology of the mitochondrial network in human cancer | Q37585762 | ||
| Targeting apoptotic and autophagic pathways for cancer therapeutics | Q37805225 | ||
| Oridonin: An active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics | Q37835927 | ||
| Core signaling pathways of survival/death in autophagy-related cancer networks | Q37884816 | ||
| Mitochondrial ROS generation for regulation of autophagic pathways in cancer | Q37939467 | ||
| MicroRNA-modulated autophagic signaling networks in cancer | Q37985341 | ||
| Caspase-mediated programmed cell death pathways as potential therapeutic targets in cancer | Q37994921 | ||
| Plant natural compounds: targeting pathways of autophagy as anti-cancer therapeutic agents | Q38024145 | ||
| Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells | Q39809734 | ||
| NF-kappab facilitates oridonin-induced apoptosis and autophagy in HT1080 cells through a p53-mediated pathway | Q39818380 | ||
| Autophagy inhibits reactive oxygen species-mediated apoptosis via activating p38-nuclear factor-kappa B survival pathways in oridonin-treated murine fibrosarcoma L929 cells | Q39888530 | ||
| Reactive oxygen species mediate oridonin-induced HepG2 apoptosis through p53, MAPK, and mitochondrial signaling pathways | Q39948397 | ||
| Oridonin induces human melanoma A375-S2 cell death partially through inhibiting insulin-like growth factor 1 receptor signaling | Q39951528 | ||
| Apoptosis-suppressing and autophagy-promoting effects of calpain on oridonin-induced L929 cell death | Q39983974 | ||
| Inactivation of ras and changes of mitochondrial membrane potential contribute to oridonin-induced autophagy in a431 cells | Q40076228 | ||
| Autophagy preceded apoptosis in oridonin-treated human breast cancer MCF-7 cells | Q40138436 | ||
| Oridonin inhibited the tyrosine kinase activity and induced apoptosis in human epidermoid carcinoma A431 cells | Q40176455 | ||
| Oridonin induced apoptosis through Akt and MAPKs signaling pathways in human osteosarcoma cells | Q40183990 | ||
| Fibroblast growth factor-2 suppresses oridonin-induced L929 apoptosis through extracellular signal-regulated kinase-dependent and phosphatidylinositol 3-kinase-independent pathway | Q40206093 | ||
| Back to the future of oridonin: again, compound from medicinal herb shows potent antileukemia efficacies in vitro and in vivo | Q40224511 | ||
| A comparison of the signal pathways between the TNF alpha- and oridonin-induced murine L929 fibrosarcoma cell death | Q40328365 | ||
| Bcl-2 up-regulation and P-p53 down-regulation account for the low sensitivity of murine L929 fibrosarcoma cells to oridonin-induced apoptosis | Q40354165 | ||
| Apoptotic effect of oridonin on NB4 cells and its mechanism | Q40397708 | ||
| P433 | issue | 6 | |
| P921 | main subject | cell death | Q2383867 |
| P304 | page(s) | 499-507 | |
| P577 | publication date | 2012-12-01 | |
| P1433 | published in | Cell Proliferation | Q1952798 |
| P1476 | title | Oridonin: targeting programmed cell death pathways as an anti-tumour agent | |
| P478 | volume | 45 |
| Q37714055 | Anti-proliferative effect of Jesridonin on paclitaxel-resistant EC109 human esophageal carcinoma cells |
| Q38773218 | Antitumor and Antibacterial Derivatives of Oridonin: A Main Composition of Dong-Ling-Cao. |
| Q92668992 | Capsaicin induces apoptosis and autophagy in human melanoma cells |
| Q37197661 | Cold-water extracts of Grifola frondosa and its purified active fraction inhibit hepatocellular carcinoma in vitro and in vivo |
| Q28387804 | Discovery and development of natural product oridonin-inspired anticancer agents |
| Q39167609 | ER stress and ASK1-JNK activation contribute to oridonin-induced apoptosis and growth inhibition in cultured human hepatoblastoma HuH-6 cells |
| Q48131676 | Effects of dietary supplementation with oridonin on the growth performance, relative organ weight, lymphocyte proliferation, and cytokine concentration in broiler chickens |
| Q36259454 | Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis |
| Q38724028 | Geridonin, a novel derivative of oridonin, inhibits proliferation of MGC 803 cells both in vitro and in vivo through elevating the intracellular ROS. |
| Q34651881 | Identifying molecular targets of lifestyle modifications in colon cancer prevention |
| Q39007335 | Lasiokaurin derivatives: synthesis, antimicrobial and antitumor biological evaluation, and apoptosis-inducing effects |
| Q38632963 | Natural products against hematological malignancies and identification of their targets |
| Q33598550 | Oridonin induces G2/M cell cycle arrest and apoptosis via the PI3K/Akt signaling pathway in hormone-independent prostate cancer cells |
| Q48105319 | Oridonin induces apoptosis in human oral cancer cells via phosphorylation of histone H2AX. |
| Q38912986 | Oridonin inhibits BxPC-3 cell growth through cell apoptosis |
| Q26738633 | Oridonin, a Promising ent-Kaurane Diterpenoid Lead Compound |
| Q38707589 | Single molecule force spectroscopy for in-situ probing oridonin inhibited ROS-mediated EGF-EGFR interactions in living KYSE-150 cells. |
| Q36913614 | Targeting signaling pathways in epithelial ovarian cancer |
| Q28548596 | The Antitumor Activity of the Novel Compound Jesridonin on Human Esophageal Carcinoma Cells |
| Q38786015 | Unravelling the relationship between macroautophagy and mitochondrial ROS in cancer therapy |
Search more.